Canada Markets closed

Abbott Laboratories (ABT)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
127.64-0.98 (-0.76%)
At close: 04:02PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close128.62
Bid127.75 x 1300
Ask129.25 x 800
Day's Range127.47 - 129.38
52 Week Range105.32 - 131.60
Avg. Volume5,009,866
Market Cap226.793B
Beta (5Y Monthly)0.67
PE Ratio (TTM)40.00
EPS (TTM)3.19
Earnings DateJan. 25, 2022 - Jan. 31, 2022
Forward Dividend & Yield1.80 (1.39%)
Ex-Dividend DateOct. 14, 2021
1y Target Est132.05
  • Reuters

    UPDATE 1-Thermo Fisher says its COVID-19 tests accurately detects Omicron variant

    Thermo Fisher Scientific Inc said on Monday its COVID-19 diagnostic tests can accurately detect the new coronavirus variant Omicron that has prompted several countries to shut their borders. The World Health Organisation (WHO) last week classified the Omicron variant as a SARS-CoV-2 "variant of concern," saying it may spread more quickly than other forms. Thermo Fisher's TaqPath COVID-19 assays can report accurate results even in the case where one of the gene targets is impacted by a mutation, the company said in a statement.

  • Zacks

    Here's Why You Should Retain Abbott (ABT) Stock For Now

    Investors are optimistic about Abbott (ABT) owing to strong third-quarter results and bullish 2021 outlook.

  • Zacks

    Why Is Abbott (ABT) Up 2.1% Since Last Earnings Report?

    Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.